Skip to content

Dry Needling and Therapeutic Exercise on Sleep in Individuals With Chronic Neck Pain and Sleep Disturbance

Effects of Dry Needling and Therapeutic Exercise on Sleep in Individuals With Chronic Neck Pain and Sleep Disturbance - A Pilot Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06275074
Enrollment
28
Registered
2024-02-23
Start date
2024-03-14
Completion date
2027-04-01
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain, Sleep Disturbance

Keywords

Needling, Sleep Disturbance, Chronic pain, Neck Pain, Actigraphy, Physical Therapy, Feasibility

Brief summary

Feasibility study investigating the effects of dry needling on individuals with chronic neck pain and sleep disturbance.

Detailed description

The purpose of this pilot study is to determine the feasibility of a large randomized clinical trial (RCT) which aims to investigate the effects of dry needling (DN) in addition to therapeutic exercise (TE) on sleep duration and quality in patients with chronic neck pain (CNP) and sleep disturbance (SD). Specifically, the objective is to explore feasibility of a study protocol and examine the preliminary data of a small sample size for the effectiveness of DN and TE for individuals with CNP and SD to determine effect size of the intervention.

Interventions

PROCEDUREDry Needling

Insertion of filiform needles into cervicothoracic multifidi, upper trapezius, and suboccipital muscles

OTHERTherapeutic Exercise

Therapeutic exercise program provided to all participants with the aim of addressing periscapular strength and postural edurance.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessors will be blinded to group assignment of participants.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Neck pain lasting greater than 3 months 28,29 * Age: 18-75 years * Presence of sleep disturbance - to be defined as a score ≥ 8 on the Insomnia Severity Index * Ability to understand study procedures and to comply with them for the entire length of the study

Exclusion criteria

* Previous surgery to the neck or thoracic spine * Central nervous system disorders * Systemic joint disease (e.g. rheumatoid arthritis) * Infection * Cancer * Raynaud's disease * Pregnancy * Immunocompromised disease (e.g., diabetes mellitus, HIV, AIDS, lupus) * Insufficient English-language skills to complete all questionnaires. * Contraindications to dry needling: * Presence of needle phobia * History of abnormal reaction to needling or injection * History of bleeding disorder (e.g., current anticoagulant therapy or known thrombocytopenia)

Design outcomes

Primary

MeasureTime frameDescription
Participant retention rate1 yearOne variable to be assessed to determine feasibility is retention rate of participants recruited and enrolled. The retention rate of participants will be calculated as follows: Retention rate = (Number of patients completing the study / Number of patients initially enrolled) x 100. Feasibility will be determined with 4-week attrition rate is less than 20%
Participant intervention adherence1 yearOne variable to be assessed to determine feasibility is intervention adherence. Adherence to therapeutic exercise program given to all participants will be assessed with an exercise diary to be completed by the participants to track exercise compliance. A new diary will be provided on a weekly basis to maintenance of records.
Number of adverse responses to treatment1 yearOccurrence of adverse responses to treatment will be accounted for at each subsequent visit after initial treatment administered (visits 3-6). Patients will be asked to complete an intake form that will inquire about their experience post-intervention and provide examples of common adverse responses to determine if such events occurred for each respective participant.

Secondary

MeasureTime frameDescription
Sleep Duration5 weeksTotal sleep time and Sleep latency via wrist actigraphy
Sleep Quality13 weeksSleep quality will be measured with the use of the Pittsburgh Sleep Quality Index (PSQI). There are seven components that range in scores of 0-3. Total scores range from 0-21 with higher scores indicating worse sleep quality.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRay Lunasin, P.T., D.P.T.

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026